Global Gadolinium-Based Contrast Agents 麻豆原创 Research Report 2024

Publication ID:

PB502244052

Publication Date:

February 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Contrast Agents for MRI
The global Gadolinium-Based Contrast Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gadolinium-Based Contrast Agents include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma and Jiangsu Hengrui Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gadolinium-Based Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadolinium-Based Contrast Agents.
Report Scope
The Gadolinium-Based Contrast Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gadolinium-Based Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadolinium-Based Contrast Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Jiangsu Hengrui Medicine
Marotrast
Agfa
Stary
Segment by Type
Linear Gadolinium-Based Contrast Agents
Macrocycle Gadolinium-Based Contrast Agents
Segment by Application
Hospital
Specialist Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gadolinium-Based Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gadolinium-Based Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Gadolinium-Based Contrast Agents 麻豆原创 Overview
1.1 Product Overview and Scope of Gadolinium-Based Contrast Agents
1.2 Gadolinium-Based Contrast Agents Segment by Type
1.2.1 Global Gadolinium-Based Contrast Agents 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Linear Gadolinium-Based Contrast Agents
1.2.3 Macrocycle Gadolinium-Based Contrast Agents
1.3 Gadolinium-Based Contrast Agents Segment by Application
1.3.1 Global Gadolinium-Based Contrast Agents 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Global Gadolinium-Based Contrast Agents 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Gadolinium-Based Contrast Agents Revenue 2019-2030
1.4.2 Global Gadolinium-Based Contrast Agents Sales 2019-2030
1.4.3 Global Gadolinium-Based Contrast Agents 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gadolinium-Based Contrast Agents 麻豆原创 Competition by Manufacturers
2.1 Global Gadolinium-Based Contrast Agents Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Gadolinium-Based Contrast Agents Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Gadolinium-Based Contrast Agents Average Price by Manufacturers (2019-2024)
2.4 Global Gadolinium-Based Contrast Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gadolinium-Based Contrast Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gadolinium-Based Contrast Agents, Product Type & Application
2.7 Gadolinium-Based Contrast Agents 麻豆原创 Competitive Situation and Trends
2.7.1 Gadolinium-Based Contrast Agents 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gadolinium-Based Contrast Agents Players 麻豆原创 Share by Revenue
2.7.3 Global Gadolinium-Based Contrast Agents 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gadolinium-Based Contrast Agents Retrospective 麻豆原创 Scenario by Region
3.1 Global Gadolinium-Based Contrast Agents 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gadolinium-Based Contrast Agents Global Gadolinium-Based Contrast Agents Sales by Region: 2019-2030
3.2.1 Global Gadolinium-Based Contrast Agents Sales by Region: 2019-2024
3.2.2 Global Gadolinium-Based Contrast Agents Sales by Region: 2025-2030
3.3 Global Gadolinium-Based Contrast Agents Global Gadolinium-Based Contrast Agents Revenue by Region: 2019-2030
3.3.1 Global Gadolinium-Based Contrast Agents Revenue by Region: 2019-2024
3.3.2 Global Gadolinium-Based Contrast Agents Revenue by Region: 2025-2030
3.4 North America Gadolinium-Based Contrast Agents 麻豆原创 Facts & Figures by Country
3.4.1 North America Gadolinium-Based Contrast Agents 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.4.3 North America Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gadolinium-Based Contrast Agents 麻豆原创 Facts & Figures by Country
3.5.1 Europe Gadolinium-Based Contrast Agents 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.5.3 Europe Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gadolinium-Based Contrast Agents 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Gadolinium-Based Contrast Agents 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gadolinium-Based Contrast Agents 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Gadolinium-Based Contrast Agents 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.7.3 Latin America Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gadolinium-Based Contrast Agents 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Gadolinium-Based Contrast Agents 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gadolinium-Based Contrast Agents Sales by Type (2019-2030)
4.1.1 Global Gadolinium-Based Contrast Agents Sales by Type (2019-2024)
4.1.2 Global Gadolinium-Based Contrast Agents Sales by Type (2025-2030)
4.1.3 Global Gadolinium-Based Contrast Agents Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Gadolinium-Based Contrast Agents Revenue by Type (2019-2030)
4.2.1 Global Gadolinium-Based Contrast Agents Revenue by Type (2019-2024)
4.2.2 Global Gadolinium-Based Contrast Agents Revenue by Type (2025-2030)
4.2.3 Global Gadolinium-Based Contrast Agents Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Gadolinium-Based Contrast Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gadolinium-Based Contrast Agents Sales by Application (2019-2030)
5.1.1 Global Gadolinium-Based Contrast Agents Sales by Application (2019-2024)
5.1.2 Global Gadolinium-Based Contrast Agents Sales by Application (2025-2030)
5.1.3 Global Gadolinium-Based Contrast Agents Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Gadolinium-Based Contrast Agents Revenue by Application (2019-2030)
5.2.1 Global Gadolinium-Based Contrast Agents Revenue by Application (2019-2024)
5.2.2 Global Gadolinium-Based Contrast Agents Revenue by Application (2025-2030)
5.2.3 Global Gadolinium-Based Contrast Agents Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Gadolinium-Based Contrast Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Gadolinium-Based Contrast Agents Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Corporation Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lantheus Gadolinium-Based Contrast Agents Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 YRPG
6.6.1 YRPG Corporation Information
6.6.2 YRPG Description and Business Overview
6.6.3 YRPG Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 YRPG Gadolinium-Based Contrast Agents Product Portfolio
6.7.5 YRPG Recent Developments/Updates
6.8 BeiLu Pharma
6.8.1 BeiLu Pharma Corporation Information
6.8.2 BeiLu Pharma Description and Business Overview
6.8.3 BeiLu Pharma Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio
6.8.5 BeiLu Pharma Recent Developments/Updates
6.9 Jiangsu Hengrui Medicine
6.9.1 Jiangsu Hengrui Medicine Corporation Information
6.9.2 Jiangsu Hengrui Medicine Description and Business Overview
6.9.3 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.10 Marotrast
6.10.1 Marotrast Corporation Information
6.10.2 Marotrast Description and Business Overview
6.10.3 Marotrast Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Marotrast Gadolinium-Based Contrast Agents Product Portfolio
6.10.5 Marotrast Recent Developments/Updates
6.11 Agfa
6.11.1 Agfa Corporation Information
6.11.2 Agfa Gadolinium-Based Contrast Agents Description and Business Overview
6.11.3 Agfa Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Agfa Gadolinium-Based Contrast Agents Product Portfolio
6.11.5 Agfa Recent Developments/Updates
6.12 Stary
6.12.1 Stary Corporation Information
6.12.2 Stary Gadolinium-Based Contrast Agents Description and Business Overview
6.12.3 Stary Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Stary Gadolinium-Based Contrast Agents Product Portfolio
6.12.5 Stary Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gadolinium-Based Contrast Agents Industry Chain Analysis
7.2 Gadolinium-Based Contrast Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gadolinium-Based Contrast Agents Production Mode & Process
7.4 Gadolinium-Based Contrast Agents Sales and 麻豆原创ing
7.4.1 Gadolinium-Based Contrast Agents Sales Channels
7.4.2 Gadolinium-Based Contrast Agents Distributors
7.5 Gadolinium-Based Contrast Agents Customers
8 Gadolinium-Based Contrast Agents 麻豆原创 Dynamics
8.1 Gadolinium-Based Contrast Agents Industry Trends
8.2 Gadolinium-Based Contrast Agents 麻豆原创 Drivers
8.3 Gadolinium-Based Contrast Agents 麻豆原创 Challenges
8.4 Gadolinium-Based Contrast Agents 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Jiangsu Hengrui Medicine
Marotrast
Agfa
Stary

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.